Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Nine injured in attack in Taipei, media reports
Putin offers no compromise on Ukraine, says EU 'robbery' failed
Bangladesh rocked by unrest after death of student leader
Suspected gunman in Brown University shooting found dead
Ukraine's Zelenskyy meets Poland's Trump-backed president at key moment in war
No evidence alleged Bondi gunmen received military training in Philippines
At least 12 killed in Nigeria mining site attack
Russian attack on Ukraine's central Cherkasy injures six, causes blackouts
